Cyclobenzaprine: A new type of anti-parkinsonian drug
- 31 December 1978
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology
- Vol. 2 (5-6) , 553-578
- https://doi.org/10.1016/0364-7722(78)90004-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Plasma Levels and Bioavailability of Cyclobenzaprine in Human SubjectsThe Journal of Clinical Pharmacology, 1977
- Quantitative evaluation of neuropharmacological trialsClinical Pharmacology & Therapeutics, 1974
- The importance of age effects on performance in the assessment of clinical trialsJournal of Chronic Diseases, 1973
- Quantification of Hand Tremor in the Clinical Neurological ExaminationIEEE Transactions on Biomedical Engineering, 1973
- Assessment of cyclobenzaprine in the treatment of spasticityJournal of Neurology, Neurosurgery & Psychiatry, 1972
- A qualitative and quantitative evaluation of amantadine in the treatment of Parkinson's diseaseJournal of Chronic Diseases, 1972
- Effects of d‐amphetamine on quantitative measures of motor performanceClinical Pharmacology & Therapeutics, 1972
- Amantadine and levodopa in the treatment of Parkinson's diseaseClinical Pharmacology & Therapeutics, 1972
- Correlation between the experimental data from animal studies and therapeutical effects of antidepressant drugsPsychopharmacology, 1971
- ParkinsonismNeurology, 1967